AgomAb Therapeutics
(NASDAQ) AGMB
AgomAb Therapeutics Financials at a Glance
Market Cap
$538.54M
Revenue (TTM)
$0.00
Net Income (TTM)
$32.77
EPS (TTM)
$0.00
P/E Ratio
0.00
Dividend
$0.00
Beta (Volatility)
-1.30 (Low)
Dividend
$0.00
Beta (Volatility)
-1.30 (Low)
Price
$11.32
Volume
171,604
Open
$11.89
Price
$11.32
Volume
171,604
Open
$11.89
Previous Close
$11.05
Daily Range
$11.10 - $12.65
52-Week Range
$9.00 - $17.45
Dividend
$0.00
Beta (Volatility)
-1.30 (Low)
Price
$11.32
Volume
171,604
Open
$11.89
Previous Close
$11.05
Daily Range
$11.10 - $12.65
52-Week Range
$9.00 - $17.45
AGMB News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout AgomAb Therapeutics
Industry
Pharmaceuticals
Sector
Health CareEmployees
62
CEO
Tim Knotnerus, PhD
Website
agomab.comHeadquarters
Antwerp, 2600, BE
AGMB Financials
Key Financial Metrics (TTM)
Gross Margin
0%
Operating Margin
0%
Net Income Margin
0%
Return on Equity
0%
Return on Capital
0%
Return on Assets
0%
Earnings Yield
N/A
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$538.54M
Shares Outstanding
48.74M
Volume
171.60K
Short Interest
0.00%
Avg. Volume
218.44K
Financials (TTM)
Gross Profit
$0.00
Operating Income
$48.02M
EBITDA
$45.88M
Operating Cash Flow
N/A
Capital Expenditure
N/A
Free Cash Flow
N/A
Cash & ST Invst.
N/A
Total Debt
N/A
AgomAb Therapeutics Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonCurrently no data to display.
Earnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$0.00
N/A
Gross Profit
$0.00
N/A
Gross Margin
0.00%
N/A
Market Cap
$538.54M
N/A
Market Cap/Employee
$9.45M
N/A
Employees
57
N/A
Net Income
$11.73M
N/A
EBITDA
$11.80M
N/A
Quarterly Fundamentals
Net Cash
$128.26M
N/A
Accounts Receivable
$0.00
N/A
Inventory
$0.00
N/A
Long Term Debt
$1.08M
N/A
Short Term Debt
$242.00K
N/A
Return on Assets
0.00%
N/A
Return on Invested Capital
0.00%
N/A
Free Cash Flow
$12.80M
N/A
Operating Cash Flow
$12.44M
N/A